Skip to main content
. 2017 Dec 9;9(1):982–994. doi: 10.18632/oncotarget.23140

Figure 2. Kaplan-Meier analysis for EP3 in EC patients.

Figure 2

Individuals with high EP3 expression exhibit impaired PFS and OS in both overall cohort (A, B) and FIGO I endometrioid cancer group (C, D) compared to those with low EP3 expression.